Results 21 to 30 of about 2,569,808 (283)

The impact of type 2 diabetes and Microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial Disease (SMART) study [PDF]

open access: yes, 2008
Aims Type 2 diabetes mellitus and microalbuminuria are important risk factors for cardiovascular disease (CVD). Whether these two complications are important and independent risk factors for future CVD events in a high-risk population with clinically ...
Algra, A.   +3 more
core   +3 more sources

Religiosity and type 2 diabetes self-management among Muslims residing in California

open access: yesHeliyon, 2023
Type 2 diabetes (T2D) is a public health issue that needs to be addressed. In the U.S., 11.3% of the population have diabetes. It is estimated that 90–95% of all diabetes cases are T2D cases.
Fatimah Alramadhan   +4 more
doaj   +1 more source

Circulating miRNAs as predictive biomarkers of type 2 diabetes mellitus development in coronary heart disease patients fromt he CORDIOPREV study [PDF]

open access: yes, 2018
Circulating microRNAs (miRNAs) have been proposed as type 2 diabetes biomarkers, and they may be a more sensitive way to predict development of the disease than the currently used tools.
Alcalá Díaz, Juan Francisco   +13 more
core   +4 more sources

MicroRNAs and type 2 diabetes [PDF]

open access: yesExRNA, 2019
MicroRNAs (miRNAs) are non-coding single strand RNAs. MiRNAs are encoded by endogenous genes with a length of about 22 nucleotides. MiRNAs play a vital role in the inhibition of post-transcriptional translation of mRNAs.
Jiali Deng, Feifan Guo
doaj   +1 more source

The genetics of type 2 diabetes [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2001
Of the various subtypes of diabetes, type 2 diabetes has the greatest impact on health worldwide. Around 150 million people have type 2 diabetes, and the prevalence will rise by 40% by 2010 [1]. Type 2 diabetes and its complications already consume 5–10% of health budgets in many countries [2].
McCarthy, M, Menzel, S
openaire   +2 more sources

Diabetes Mellitus Type 2

open access: yesSouth African Family Practice, 2004
No abstract available.
Medical Schemes
doaj   +1 more source

The PPARγ2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus [PDF]

open access: yes, 2016
The high mortality risk of patients with type 2 diabetes mellitus may well be explained by the several comorbidities and/or complications. Also the intrinsic genetic component predisposing to diabetes might have a role in shaping the risk of diabetes ...
Alberico, Federica   +13 more
core   +1 more source

A Survey of Autoantibodies to Self Antigens in Graves' Disease Patients with Thyroid-Associated Ophthalmopathy

open access: yesEuropean Journal of Inflammation, 2013
Thyroid Associated Ophthalmopathy (TAO) is a complex pathology to treat and a considerable threat for Graves' Disease (GD) patients. Thus, there is great interest to find tools able to predict the onset and prognosis of TAO.
R. Bei   +14 more
doaj   +1 more source

The prevention of type 2 diabetes [PDF]

open access: yesNature Clinical Practice Endocrinology & Metabolism, 2008
Type 2 diabetes mellitus (T2DM) affects more than 7% of adults in the US and leads to substantial personal and economic burden. In prediabetic states insulin secretion and action--potential targets of preventive interventions--are impaired. In trials lifestyle modification (i.e. weight loss and exercise) has proven effective in preventing incident T2DM
Jill P, Crandall   +8 more
openaire   +2 more sources

IL-6 and Type 2 Diabetes

open access: yesمجلة كلية الطب, 2010
Background: Interleukin -6 (IL-6) as the key mediator of the acute phase reaction is of interest .elevated protein concentrations of IL-6 in the blood have been shown in patients with type 2 diabetes. This study aimed to investigate the association of IL-
Maha F. Almelan
doaj   +1 more source

Home - About - Disclaimer - Privacy